During the past decade, Policlinico Universitario conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Policlinico Universitario" #1 sponsor was "Fondazione Italiana Linfomi ONLUS" with 1 trials, followed by "Gilead Sciences" with 1 trials sponsored, "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 1 trials sponsored, "Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Policlinico Universitario" #1 collaborator was "Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte" with 2 trials as a collaborator, "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator and "University of Turin, Italy" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Policlinico Universitario" are "Ankylosing Spondylitis" (1 trials), "Chronic Hepatitis B" (1 trials), "Diffuse Large B-Cell Lymphoma" (1 trials), "IPI≥2" (1 trials) and "Lymphoblastic Leukemia, Acute" (1 trials). Many other conditions were trialed in "Policlinico Universitario" in a lesser frequency.

Most popular intervention types in "Policlinico Universitario" are "Drug" (4 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (2 trials), "ARA-C" (1 trials), "ASCT" (1 trials), "BCNU" (1 trials) and "Ciclofosfamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Policlinico Universitario" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Policlinico Universitario". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Policlinico Universitario, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Policlinico Universitario, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".